Open AccessP1421: BIMODAL TARGETING OF CYTOKINE RECEPTOR‐LIKE FACTOR 2 (CRLF2) WITH JAK INHIBITION AND CHIMERIC ANTIGEN RECEPTOR T CELL IMMUNOTHERAPY IN DOWN SYNDROME ACUTE LYMPHOBLASTIC LEUKEMIA
Author(s) -
Bagashev A.,
Loftus J.,
Niswander L.,
Ross S.,
Falkenstein C. D.,
Junco J.,
Rabin K. R.,
Fry T.,
Tasian S. K.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000848544.25019.34
Subject(s) - ruxolitinib , medicine , cytokine , cytokine release syndrome , chimeric antigen receptor , immunotherapy , cancer research , immunology , immune system , bone marrow , myelofibrosis